Treatment Outcomes of Eosinophilic Granulomatosis with Polyangiitis (EGPA):A Retrospective Analysis of US Health Insurance Claims Data

被引：0
|
作者：
Dolin, Paul [1 ]
Shavit, Anat [1 ]
Keogh, Karina A. [2 ]
Rowell, Jennifer [3 ]
Edmonds, Chris [4 ]
Kielar, Danuta [1 ]
Meyers, Juliana [5 ]
Esterberg, Elizabeth [5 ]
Nham, Tram [5 ]
Chen, Stephanie Y. [6 ]
机构：
[1] AstraZeneca, BioPharm Med, Cambridge, England
[2] Div Pulm & Crit Care Med, Dept Internal Med, Mayo Clin, Rochester, MN USA
[3] AstraZeneca, Market Access & Pricing, Cambridge, England
[4] AstraZeneca, Market Access & Pricing, Gaithersburg, MD USA
[5] RTI Hlth Solut, Res Triangle Pk, NC USA
[6] AstraZeneca, BioPharm Med, Gaithersburg, MD USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2491
引用
收藏
页码：5072 / 5073
页数：2
相关论文
共 50 条
  • [31] REAL-WORLD BIOLOGICS USE IN EUROPEAN PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): CHARACTERISTICS AND OUTCOMES
    Hwee, J.
    Huynh, L.
    Baylis, L.
    Alfonso-Cristancho, R.
    Khanal, A.
    da Costa, W.
    Duh, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S12 - S13
  • [32] Renal involvement in eosinophilic granulomatosis with polyangiitis (EGPA): a multicentric retrospective study of 63 biopsy-proven cases
    Durel, Cecile-Audrey
    Sinico, Renato A.
    Teixeira, Vitor
    Jayne, David
    Belenfant, Xavier
    Marchand-Adam, Sylvain
    Pugnet, Gregory
    Gaultier, Jacques
    Le Gallou, Thomas
    Titeca-Beauport, Dimitri
    Agard, Christian
    Barbet, Christelle
    Bardy, Antoine
    Blockmans, Daniel
    Boffa, Jean-Jacques
    Bouet, Julien
    Cottin, Vincent
    Crabol, Yoann
    Deligny, Christophe
    Essig, Marie
    Godmer, Pascal
    Guilpain, Philippe
    Hirschi-Santelmo, Sandrine
    Rafat, Cedric
    Puechal, Xavier
    Taille, Camille
    Karras, Alexandre
    RHEUMATOLOGY, 2021, 60 (01) : 359 - 365
  • [33] COUNTRY DIFFERENCES IN THE CLINICAL MANIFESTATIONS AND TREATMENT PATTERNS OF PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): A EUROPEAN PERSPECTIVE
    Jakes, R.
    Kwon, N.
    Huynh, L.
    Hwee, J.
    Baylis, L.
    Alfonso-Cristancho, R.
    Du, S.
    Khanal, A.
    Duh, M. S.
    VALUE IN HEALTH, 2022, 25 (12) : S284 - S285
  • [34] Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative study
    Mattioli, Irene
    Urban, Maria Letizia
    Padoan, Roberto
    Mohammad, Aladdin J.
    Salvarani, Carlo
    Baldini, Chiara
    Berti, Alvise
    Cameli, Paolo
    Caminati, Marco
    Cathebras, Pascal
    Bianchi, Fulvia Chieco
    Cinetto, Francesco
    Tervaert, Jan Willem Cohen
    Coppola, Angelo
    Costanzo, Giulia
    Cottin, Vincent
    Crimi, Claudia
    Del Giacco, Stefano
    Desaintjean, Charlene
    Egan, Allyson
    Espigol-Frigole, Georgina
    Folci, Marco
    Fornaro, Marco
    Franceschini, Franco
    Govoni, Marcello
    Groh, Matthieu
    Guarnieri, Gabriella
    Hellmich, Bernhard
    Iannone, Florenzo
    Jones, Rachel
    Kernder, Anna
    Lo Gullo, Alberto
    Lombardi, Carlo
    Lopalco, Giuseppe
    Losappio, Laura
    Marchi, Maria Rita
    Rivera, Carlos Martinez
    Marvisi, Chiara
    Maule, Matteo
    Moi, Laura
    Monti, Sara
    Moosig, Frank
    Moroncini, Gianluca
    Negrini, Simone Matteo
    Neumann, Thomas
    Nolasco, Santi
    Novikov, Pavel
    Roccatello, Dario
    Samson, Maxime
    Schroeder, Jan Walter
    JOURNAL OF AUTOIMMUNITY, 2025, 153
  • [35] Utilizing Machine Learning with Claims Data to Diagnose and Quantify the Prevalence of Eosinophilic Granulomatosis with Polyangiitis
    Merkel, Peter
    Baudy, Peter
    Carstens, Donna
    North, Benjamin
    Danka, Mahvish
    Roy, Stephanie
    Marshall, Hanna
    Chupp, Geoffrey
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 3280 - 3282
  • [36] Utilizing Machine Learning with Claims Data to Diagnose and Quantify the Prevalence of Eosinophilic Granulomatosis with Polyangiitis
    Chupp, Geoffrey
    Baudy, Peter
    Carstens, Donna
    North, Benjamin
    Danka, Mahvish
    Roy, Stephanie
    Marshall, Hanna
    Merkel, Peter
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB215 - AB215
  • [37] HEALTHCARE RESOURCE UTILIZATION AND ASSOCIATED COSTS IN PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) IN ENGLAND: A RETROSPECTIVE OBSERVATIONAL COHORT STUDY
    Siddiqui, S.
    Dolin, P.
    Shavit, A.
    Rowell, J.
    Edmonds, C.
    Kielar, D.
    Persson, J.
    Lacetera, A.
    Suarez-Sanchez, P.
    Ariti, C.
    Podmore, B.
    Velarde, A. Kitchin
    Chen, S. Y.
    VALUE IN HEALTH, 2024, 27 (12) : S139 - S140
  • [38] Effectiveness of Low-Dose Mepolizumab in the Treatment of Eosinophilic Granulomatosis with Polyangiitis (EGPA): A Real-Life Experience
    Ozturk, Betul Ozdel
    Yavuz, Zeynep
    Aydin, Omur
    Mungan, Dilsad
    Sin, Betul Ayse
    Demirel, Yavuz Selim
    Bavbek, Sevim
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2022, 183 (12) : 1281 - 1290
  • [39] Efficacy and Safety Analysis of Mepolizumab in the Treatment of Eosinophilic Granulomatosis with Polyangiitis
    Ou, Changxing
    Lin, Wenmin
    Wu, Yue
    Zhang, QingLing
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [40] TREATMENT PATTERNS OF PATIENTS WITH MIGRAINE IN JAPAN: A RETROSPECTIVE ANALYSIS OF HEALTH INSURANCE CLAIMS DATA
    Meyers, J.
    Davis, K.
    Lenz, R.
    Xue, F.
    CEPHALALGIA, 2016, 36 : 161 - 161
12345